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1. Introduction 
Neurocritical care is at the forefront of bringing effective new therapies to patients with life 
threatening neurological diseases. Neurocritical care units have evolved from neurosurgical 
units focused primarily on postoperative monitoring to units that provide comprehensive 
medical and specialized neurological support for patients with life-threatening neurological 
diseases. In addition to standard interventions, areas of expertise unique to neurocritical 
care include management of intracranial pressure, hemodynamic augmentation to improve 
cerebral blood flow, therapeutic hypothermia, and advanced neuromonitoring. 
Neurointensivists defragment care by focusing on the interplay between the brain and other 
systems, and by integrating all aspects of neurological and medical management into a 
single care plan. Outcomes research has established that victims of traumatic brain injury 
and hemorrhagic stroke experience reduced mortality, better functional outcomes, and 
reduced length of stay when cared for by neurointensivists in a dedicated neurointensive 
care unit (Rincon & Mayer 2007). This chapter aims to provide an overview of global organ 
support of the critically ill neurosurgical patient.  
2. Critical care for neurosurgical patients 
The neurocritical care unit provides a venue where advanced monitoring enables 
optimisation of oxygen and metabolite delivery to the neurons by aggressive, often invasive 
interventions within a controlled environment.  
2.1 Brain monitoring 
The word “monitor” originates from the Latin monere (to warn). Monitoring merely 
provides warning of pathology and may track its progression long before it becomes 
clinically obvious thus allowing earlier aggressive management of underlying disease and 
assessment of response to therapy. The superiority of any one mode of monitoring over 
another has never been proven. 
Available forms of brain monitoring include 
Measurement of intra cranial pressure (ICP): ICP has traditionally been measured by a 
ventricular drain connected by a fluid coupled system to an external strain gauge.  
Currently, available options include systems with micro strain gauges or fibreoptics built 
into the tip. Catheters may be placed in the parenchyma, subarachnoid, epidural or 
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subdural spaces in addition to the ventricles. Generally, parenchymal catheters with micro 
strain gauges in the tip have good correlation with ventricular drain pressures. 
Subarachnoid, subdural and epidural catheters are thought to be less accurate.  
Micro strain gauge and fibreoptic catheters need to be calibrated prior to insertion and 
cannot be recalibrated in situ. Theoretical concerns have been raised about measurement 
drift and resulting inaccuracy of measurement. There is little by way of published literature 
and the actual device selection is guided by institutional preference. 
Measurement of cerebral blood flow: Transcranial Doppler monitoring is an easily available, 
reproducible, non invasive and inexpensive means of measuring cerebral blood flow by 
measuring flow velocity in the middle cerebral artery (MCA). It has been used to assess for 
cerebral vasospasm, to assess cerebral autoregulation (Reinhard et al, 2010) and diagnose 
traumatic dissection of the internal carotid artery (Bouzat et al, 2010). 
Measurement of brain oxygenation: Jugular venous oxymetry (SjO2) has been used to assess 
oxygen delivery to the brain. Both low (<55%) and high (>75%) SjO2 have been associated 
with poor outcomes. The arterio jugular difference in oxygen content has been measured to 
assess cerebral oxygen extraction.  
Brain tissue oxygenation (PBrO2) can be directly measured by placing catheters into affected 
areas of the brain to detect focal ischaemia. PBrO2<15 mmH is associated with poor 
neurologic outcome.  
Near infra red spectroscopy (NIRS) has been mooted as a non invasive measure of regional 
transcranial oxygen saturation (rSO2). Though promising, its routine use in neurocritical care 
is potentially impeded by the presence of scalp wounds, hematoma and intracranial catheters.  
Assessment of metabolic state: Cerebral microdialysis catheters placed directly into brain 
tissue have been used to measure levels of brain metabolites. The commonly measured ones 
are glucose, lactate, glutamate, pyruvate and lactate/pyruvate ratio. The use of these 
devices is uncommon outside of larger academic centres. Given the paucity of correlation 
with outcomes data, their routine use cannot currently be recommended.  
Assessment of electrical activity: This has traditionally been done using 
electroencephalography (EEG). Its widespread use in critical care has been impeded by 
difficulties in the interpretation of EEGs by non neurologists.  
Bispectral index (BIS) is a processed EEG monitoring tool that evaluates brain electrical 
activity for zero (flat line EEG) to 100 (awake patient). It is not in routine use currently in 
critical care environments.  
Somatosensory evoked potentials (SEP) have been validated for prognostication after 
hypoxic brain injury. Delayed N20 bilaterally has been shown to correlate with poor 
neurologic outcome. 
2.2 Management of ICP 
ICP in normal subjects is usually less than 10 mmHg. It is generally accepted that active 
treatment for elevated ICP should be initiated for sustained rises in ICP to greater than 20 
mmHg. The definitive treatment of elevated ICP remains, of course, management of the 
underlying pathology.  
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The following sequence of events is a suggested escalating way of medically managing 
elevated ICP to return it to <20mmHg. It is useful to simultaneously maintain a cerebral 
perfusion pressure (CPP) >60 mmHg, where CPP is the difference between mean arterial 
pressure (MAP) and ICP 
• If the patient is not already intubated, consideration should be given to intubating and 
mechanically ventilating the patient to facilitate deep sedation 
• The patient should be nursed 30-45° head up, if possible with head in neutral position 
and ties around the neck (eg. endotracheal tube tapes, cervical collars) loosened or 
repositioned if possible 
• Ventilation titrated to normoxia (SaO2>90 mmHg, PaO2>70 mmHg) and normocapnia 
(PCO2 35-45 mmHg) 
• Liberal opiate analgesia  
• Liberal sedation targeting Richmond Agitation and Sedation Scale (RASS) -4 or lower.  
• Neuromuscular blockade if frequent shivering or coughing 
• Prompt treatment of any seizure activity 
• Addition of phenobarbitone 
• Hyperosmolar therapy (either 0.5-1 gm/kg of mannitol or 3% NaCl to target serum 
sodium ~150) 
• Hyperventilation to PCO2<25 mmHg 
• At this stage, consideration should be given to immediate evacuation of any mass 
lesions. Consideration should also be given to placing a ventricular catheter to drain 
CSF.  
• Induction of hypothermia 
• Consideration should be given at this stage to extreme measures like decompressive 
craniotomy or thiopentone infusion   
2.3 Sedation, analgesia and neuromuscular blockade 
A variety of drugs are commonly used to sedate and treat pain in critically ill ventilated 
patients. 
It is inhumane to deny analgesia to a patient for fear of clouding neurologic signs. 
Adequate analgesia minimises noxious stimuli which may contribute to elevated ICP, 
ventilator dyssynchrony and reactive hypertension. In addition, opiates have sedative 
properties and can be used alone for sedation or in combination with other sedative 
agents. Morphine is traditionally the drug of choice. The author’s practice is to be liberal 
with opiates and wherever possible, to use patient controlled analgesia. Fentanyl and 
sufentanyl have been associated with small but definite rises in ICP. To minimise this, 
they may be administered slowly intravenously. Regular administration of paracetamol 
may reduce opiate requirements. In a peri operative setting, non steroidal anti 
inflammatories may be used with caution, allowing for the impact on kidneys, 
gastrointestinal tract and platelet function. 
Sedation allows tube tolerance in most intubated critical care patients. In a neurosurgical 
setting, sedation is neuroprotective and reduces cerebral oxygen demand and cerebral 
metabolism. The commonly available agents available for sedation are benzodiazepines and 
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propofol. Given the association between benzodiazepines and increased delirium, the 
author’s preferred first line agent is propofol, where haemodynamics permit. Caution needs 
to be exercised where more than 5 mg/kg/hour is being infused for more than 24 hours. 
Midazolam infusion is a reasonable alternative and, where clinically indicated, the two may 
be combined. The author’s practice is to give daily sedation breaks as soon as clinically 
feasible. Alpha blockers like clonidine or dexmedetomidine should be considered for 
emergence delirium and as adjuncts to analgesia. Barbiturates are not routinely used for 
sedation in an ICU setting. 
Neuro muscular blockade may be necessary for ongoing shivering, coughing or movement 
causing significant rise in ICP. It may also be needed to facilitate procedures and intra 
and/or inter hospital transport. This needs to be balanced against the association between 
neuromuscular blockade and the development of critical illness polymyoneuropathy which, 
in turn, can worsen outcomes prolong time on ventilator, ICU stay and hospital stay. The 
author’s practice is to use small doses of non depolarising agents (vecuronium or 
atracurium) when clinically indicated.  
2.4 Seizure management and prophylaxis 
Craniotomies, especially supratentorial ones, are associated with a high incidence of post 
operative seizures. Depending on the reason for surgery, up to 50% patients have at least 
one seizure treated postoperatively (Shaw & Foy, 1991). There are no formal guidelines for 
routine seizure prophylaxis after neurosurgery in general.  
Prophylactic anticonvulsants should not be used routinely in patients with newly diagnosed 
brain tumours. Anti convulsants should be tapered and discontinued after the first 
postoperative week in patients who have not had seizures (Glantz et al, 2000). 
In traumatic brain injury, anticonvulsants are indicated to decrease the incidence of early 
post traumatic seizures (within 7 days of trauma). Early post traumatic seizures are not 
associated with worse outcomes. Phenytoin has been shown to reduce the incidence of early 
post traumatic seizures. Valproate has an effect comparable to phenytoin in reducing early 
post tramatic seizures but may be associated with higher mortality (Brain Trauma 
Foundation Guidelines, 3rd ed). Routine use of anticonvulsants is not recommended later 
than 1 week following head injury to prevent late post traumatic seizures and does not 
reduce their incidence.  
2.5 Hyperosmolar therapy 
Hyperosmolar therapy is often used to treat elevated ICP. It may buy time to do diagnostic 
(eg. imaging) or therapeutic (eg. evacuation of mass lesion) interventions. In the absence of 
ICP monitoring, its use should be restricted to patients with signs of transtentorial 
herniation or deteriorating neurologic state not attributable to extra cranial causes. 
The two agents in common use are mannitol and hypertonic saline. 
Mannitol in the dose range of 0.25-1 gm/kg as a bolus is effective in reducing ICP. While it 
has been used as prolonged therapy for raised ICP, there is lack of evidence to recommend 
repeated regular administration of mannitol over several days. Serum osmolarity should be 
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monitored when mannitol is being administered, especially if repeated doses are being 
considered. While mannitol acts by increasing serum osmolarity, there is significant risk of 
acute kidney injury at high serum osmolarities. While there is no absolute threshold for a 
particular patient, osmolarities of more than 320 mOsm/L are likely to be hazardous. In the 
neurosurgical patient with a compromised blood brain barrier, theoretical concerns have 
also been raised regarding mannitol causing osmotic oedema in the injured areas of the 
brain, further compromising perfusion to these areas.  
Hypertonic saline acts by osmotic mobilisation of water and reduction of total cerebral 
water content. It is usually well tolerated, cheap and easy to titrate off serum sodium levels, 
which are routinely measured in most intensive care units. Caution must be exercised in its 
liberal use in patients with chronic hyponatremia due to the risk of inducing central pontine 
myelinolysis. There is not enough strong evidence at present to make recommendations 
regarding the concentration or method of administration of hypertonic saline for treatment 
of raised ICP. As unmeasured hyperosmolar particles (such as mannitol) are not introduced 
to the serum, adequate osmolar monitoring is readily available from the serum sodium 
level. The author’s practice is to use 20 ml aliquots of 3% NaCl aiming for a serum sodium 
level ~150 mmol/L.  
There is a paucity of data on the safety and efficacy of combined hyperosmolar therapy with 
mannitol and hypertonic saline.  
2.6 Induced hypothermia 
Mild induced hypothermia (core temperature 32-34°C) has been thought to offer 
neuroprotection by reducing cerebral oxygen demand, altering the inflammatory cascade 
and reducing ICP.  
There is no clear evidence that induced hypothermia reduces mortality in a neurosurgical 
population. In patients undergoing temporary clipping for aneurysm surgery, hypothermia 
was not associated with improved neurologic outcomes (Hindman et al 2010). A multi 
centre trial is currently under way to assess 6 month functional outcome after induction of 
hypothermia in patients with brain trauma (North American Brain Injury Study: 
Hypothermia IIR, Clifton et al, 2009).  
3. Extracranial organ support in the neurocritical care unit 
Critically unwell neurosurgical patients also need ongoing management of other organ 
systems and management of other non brain pathologies. Critical care interventions on extra 
cranial organs have implications for cerebral circulation and metabolism. Appropriate care 
also minimises secondary injury to the brain after primary insults like trauma.  
3.1 Respiratory support  
Mechanical ventilation has rapidly evolved in recent years, guided primarily by improved 
understanding of pathophysiology. Neurosurgical patients heavily rely on ventilation for 
support, and less commonly, for therapy. Meeting ventilation needs of these patients while 
minimising ventilator induced lung injury can be challenging (Johnson et al, 2007).  
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The purpose of ventilator support may loosely be divided into those of optimising systemic 
arterial oxygenation (PaO2) and oxygen saturation (SaO2) and regulating partial pressure of 
carbon dioxide in arterial blood (PaCO2). 
Hypoxia (PaO2<60 and/ or SaO2<90) is associated with poor neurologic outcomes in 
patients with acute brain injuries (Young et al 2010). The duration of hypoxia itself is an 
independent predictor of mortality (Jones et al 1994). The physiologic response to cerebral 
hypoxia is increased cerebral blood flow. In the context of elevated intracranial pressure, the 
resultant increase in intracranial blood volume is likely to exacerbate intracranial 
hypertension. This can be rapidly corrected by ventilating to normoxia (SaO2>90, PaO2>70) 
and often requires intubation and mechanical ventilation. 
While primary insults like trauma cause areas of focal hypoperfusion of the brain, there is 
no conclusive evidence supporting attempts to achieve supra normal PaO2 to improve local 
oxygen delivery. Extreme hyperoxemia may be detrimental in patients with severe 
traumatic brain injury (Davis et al 2009). Certainly, among patients admitted to intensive 
care after resuscitation from cardiac arrest, hyperoxia (PaO2>300) is associated with 
increased risk of in hospital mortality (Kilgannon et al, 2010). 
Historically, aggressive hyperventilation to induce hypocapnia (PaCO2<25) has been 
advocated to reduce intracranial pressures (ICP). While hyperventilation certainly reduces 
ICP, the mechanism by which this occurs is cerebral vasoconstriction, reducing cerebral blood 
flow and ultimately, compromising blood flow to brain tissue. Prophylactic hyperventilation is 
no longer recommended and this intervention should be limited to being a temporising 
measure in the management of intractably elevated ICP. Its benefits may be outweighed by 
risks in the first 24 hours after acute brain insult when perfusion to the brain is poor and, 
where available, should be used in conjunction with monitoring of cerebral perfusion like 
jugular venous saturation (JvSO2). (Brain trauma foundation guidelines edition 3). 
Hypercapnia (PCO2>50) causes cerebral vasodilation, increasing cerebral blood volume and 
thereby ICP. The optimal strategy would be to aim for normocapnia (PaCO2 35-45).  
Positive end expiratory pressure (PEEP) improves oxygenation and forms part of routine 
lung protective ventilation strategies. Traditionally, concerns have been raised regarding the 
use of PEEP in ventilating neurosurgical patient as it may increase ICP and, by extension, 
reduce cerebral perfusion pressure (CPP). Low levels of PEEP to improve alveolar 
recruitment have been shown to not change ICP (Mascia et al 2005). Increasing PEEP to as 
high as 15 cmH2O to improve oxygenation was paradoxically associated with decreases in 
ICP and improved CPP (Huynh et al 2002).  
Reasonable goals of ventilation would be to achieve SaO2>90, PaO2>70, PCO2 35-45. Lung 
protective ventilator strategies (low tidal volumes 6-8 ml/kg, judicious use of PEEP) would 
meet the ventilatory requirements of the majority of neurosurgical patients. Additional 
measures such as loosening tapes securing endotracheal tubes and optimum head 
positioning and head elevation to prevent jugular outflow obstruction would be of benefit to 
maintaining adequate CPP.   
3.2 Cardiovascular support 
The goal of all resuscitation is the delivery of oxygen and metabolites to end organs. 
Hypotension, defined as a systolic blood pressure less than 90 mmHg, has been shown to 
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worsen outcomes from acute brain injury. Even isolated episodes of in hospital hypotension 
have been associated with increased mortality and morbidity (Jones et al, 1994). Due to 
ethical considerations, there is no Class I evidence on the effect of haemodynamic 
resuscitation on outcomes. However, raising the blood pressure improves outcome in 
proportion to the efficacy of the resuscitation (Vassar et al 1993).  
The ideal fluid for volume resuscitation remains controversial. 0.9% NaCl remains the most 
commonly used fluid for this purpose, probably for reasons of familiarity, cost and ease of 
use. There is little conclusive evidence to support colloid over crystalloid therapy. The SAFE 
study suggested similar outcomes from fluid resuscitation with saline or 4% albumin. A 
post hoc analysis of the SAFE study data suggested higher mortality rates associated with 
fluid resuscitation with albumin compared to saline in patients with traumatic brain injury 
(SAFE study investigators, 2007). A multi centre randomised trial is currently under way 
comparing outcomes of resuscitation with saline and starch. 
It is reasonable to use vasopressors and inotropes as needed to defend MAP and, by 
extension, CPP. There is no conclusive evidence to prove the superiority of any vasoactive 
agent over another. The use of these drugs is often determined by local critical care practice. 
The author’s vasopressor of choice is noradrenaline. 
The systolic blood pressure of 90 mmHg itself is a statistical rather than a physiological 
threshold. It makes more sense to try and approximate the patient’s baseline blood pressure 
with hemodynamic therapies than chase an artificial statistical target. The author’s practice 
is to stay within 20% of the patient’s baseline blood pressure, where known.  
Cerebral perfusion is reliant more on the systemic mean arterial pressure (MAP) and ICP. 
The MAP may be a more meaningful end point of resuscitation to aim for. Autoregulation of 
blood flow breaks down in most vascular beds below ~60 mmHg. Thus, assuming a 
“normal” ICP of 10 cmH20 and intact cerebral vasculature, a MAP of 70 mmHg would be a 
reasonable initial target. Clearly, the above caveats are not necessarily true for many 
neurosurgical patients and, in the presence of ICP monitoring, the MAP can be titrated to 
maintain a CPP>60 mmHg. Alternately, in the presence of cerebral oxygenation monitoring 
(eg. JvSO2), the MAP can be titrated to adequate cerebral oxygenation.  
There is no conclusive evidence for elevating MAP to supra normal targets. This may well 
be hazardous in the context of trauma or recent surgery, with concomitant disruption of the 
blood brain barrier and cannot be recommended in routine neuro critical care practice. 
3.3 Nutrition 
There is no disease process that benefits from lack of nutritional support. Critically unwell 
patients are hypercatabolic and at risk of losing significant lean body mass in the absence of 
nutritional support. Current practice would be to attempt to initiate nutrition early (within 
72 hours) aiming to establish full calorific replacement within 7 days. Clearly this would be 
modified for patients presenting with evidence of poor nutritional state at baseline. Enteral 
nutrition, by gastric or jejunal routes, is the preferred route. In the event of inability to access 
the gut or failure to establish enteral nutrition within a reasonable time frame, parenteral 
nutrition should be considered.  
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Patients with traumatic brain injuries often have gastroparesis. Many drugs routinely 
administered in a critical care setting further alter gut motility. This is particularly true of 
opiates. Prokinetics (eg metoclopramide 10-20 mg 6 hourly) should be considered early in 
the establishment of enteral nutrition.  
Reasonable goals of nutrition support should aim for 25-30 kcal/kg/day, of which 0.5-2 
gm/kg/day should be protein content and 30-40% non protein content should be lipids. It is 
important to also supplement fat and water soluble vitamins and trace elements.   
3.4 Glycemic control 
Hyperglycemia is common in critically ill patients and is associated with morbidity and 
mortality in varying groups of patients.  
In 2001, the Leuven Intensive Insulin Therapy Trial was published (van den Berghe et al, 2001), 
suggesting dramatic reductions in mortality in critically ill surgical patients with tight 
glycaemic control (target blood sugar 4.4-6.1 mmol/L). Subsequent studies failed to replicate 
these findings. Concerns were also raised regarding the risks of hypoglycaemia, increased 
resource use and the difficulty of achieving tight normoglycemia in critically ill patients.  
The NICE-SUGAR study (Finfer et al, 2009) suggested blood glucose levels less than 10 
mmol/L resulted in lower mortality than a target of 4.5-6 mmol/L. The author’s current 
practice is to aim for a blood sugar level of 5-10 mmol/L.  
3.5 Stress ulcer prophylaxis 
Stress ulcers are a known complication of a variety of critical illnesses. They occur as a 
consequence of hypoperfusion of the mucosa of the upper gastro intestinal tract. It is 
common practice to provide prophylaxis to decrease the incidence of clinically significant 
bleeding. 
The most commonly used classes of drugs used for this purpose are H2 antagonists, proton 
pump inhibitors and sucralfate. To a large extent, the agent used is dictated by local critical 
care practice. 
H2 antagonists have been shown to be more effective than sucralfate, antacids and placebo 
in preventing stress ulcers (Stollman & Metz, 2005). However, concerns have been raised 
regarding the association between acid suppressive treatment and ventilator associated 
pneumonia (Cook et al, 1998). Ranitidine has been associated more strongly with 
nosocomial pneumonia than sucralfate (Messori et al, 2000). Further concerns have been 
raised regarding encephalopathy and cytochrome P450 induction by H2 antagonists. 
Omeprazole was shown to reduce clinically significant gastrointestinal bleeding compared 
to ranitidine (Levy et al, 1997). A recent single centre study found a higher association of 
nosocomial pneumonia with pantoprazole compared to ranitidine in cardiac surgical 
patients (Miano et al, 2009). Both H2 antagonists and proton pump inhibitors have been 
associated with increased risk of developing community and hospital acquired Clostridium 
difficile associated disease (CDC, 2005). 
In keeping with the above, a recent systematic review was unable to find the most 
appropriate form of prophylaxis for neurocritical care patients (Schirmer et al, 2011). The 
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most sensible approach appears to be aggressive haemodynamic resuscitation to improve 
mucosal perfusion in the upper gastrointestinal tract and the establishment of early enteral 
nutrition, where possible. It is standard Australian practice to prescribe stress ulcer 
chemoprophylaxis and both H2 antagonists and proton pump inhibitors are commonly 
used. 
3.6 Thromboprophylaxis 
Critically ill neurosurgical patients are at high risk of developing venous thromboembolism. 
The incidence of deep vein thrombosis (DVT) in patients with traumatic brain injury is 
estimated to be as high as 20% (Brain Trauma Foundation Guidelines, 3rd ed.). Pulmonary 
emboli (PE) are associated with high rates of mortality and morbidity in hospitalised 
patients. Treatment of PE in neurosurgical patients is often complicated by uncertainty 
regarding the safety of anticoagulation soon after craniotomy or intracranial haemorrhage. It 
makes sense to try and prevent DVT than have to treat the PE. 
Options for DVT prophylaxis are mechanical (graduated compression stockings and 
sequential calf or foot compression devices) or chemical (low dose heparin or low dose low 
molecular weight heparin). Recent studies have failed to prove the superiority of low 
molecular weight heparins over low dose unfractionated heparin (Cook et al 2011, 
Goldhaber et al 2002) 
Mechanical interventions have low risk of complications and should be offered to all 
patients. Caution needs to be exercised in patients with severe peripheral vascular disease 
and limb trauma may preclude their use in some cases.  
Both low molecular weight heparin and unfractionated heparin have been shown to be 
effective for prophylaxis of venous thromboembolism in elective neurosurgery (Ioro & 
Agnelli, 2000). In traumatic brain injury, the risk versus benefit analysis must be made on a 
case by case basis. There appears to be little difference in the incidence of DVT or PE in 
patients receiving chemical prophylaxis after 72 hours of admission compared to those 
receiving prophylaxis earlier than 72 hours (Kim et al, 2002). In the event that chemical 
prophylaxis cannot be initiated within 72 hours of admission, consideration should be given 
to a vena caval filter. 
4. Prognostication in neurocritical care 
The outcome of critically ill neurosurgical patients after significant brain insult remains 
uncertain. Patients may survive to a cognitively impaired dependent state or worse, in a 
minimally conscious or persistently vegetative state with resultant implications for resource 
use.  
Prediction of outcome involves making probability statements that depend on a logical 
relationship between outcome and features encapsulated in antecedent data. It still remains 
impossible to predict with certainty the outcomes of an individual patient. 
In a neurocritical care population, the groups most widely studied in this context are those 
with traumatic brain injury and hypoxic brain injury. 
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4.1 Traumatic brain injury 
The brain trauma foundation has published prognostic parameters for traumatic brain 
injury. The following factors have been considered 
• Glasgow Coma Scale (GCS) score: If the initial GCS is reliably obtained and not tainted 
by pre hospital medications or intubation, there is increasing probability of poor 
outcome with a low GCS in a continuous stepwise manner. Approximately 20% 
patients with initial GCS 3 will survive and 8-10% will have a functional survival. 
• Age: There is increasing probability of poor neurologic outcome with age, with a 
significant rise in poor outcomes in age>60 years. 
• Bilaterally absent pupillary light reflex is a predictor of poor neurologic outcome 
• Hypotension (systolic BP<90 mmHg) alone has a positive predictive value (PPV) of 67% 
for poor neurologic outcome. In conjunction with hypoxia (SaO2<90%), the PPV for 
hypotension rises to 79% 
• Presence of abnormalities on initial CT study: Compressed or absent basal cisterns, 
traumatic subarachnoid haemorrhage and midline shift at the level of the foramen of 
Monro are predictive of poor neurological outcomes. 
• The Marshall score (Marshall et al, 1991) was developed from the Trauma Coma Data 
Bank (TCDB) for estimating the severity of diffuse axonal injuries seen on CT (Table 1). 
Marshall scores of 3 or higher are associated with dramatically higher incidence of 
mortality.  
 
Grade Definition 
I No visible intracranial pathology seen on CT scan 
II 
Cisterns present; midline shift 0–5 mm and/or lesion densities present; no 
high or mixed density lesion >25 cc 
III 
Cisterns compressed or absent with midline shift 0–5 mm; no high or mixed 
density lesion >25 mm 
IV 
Midline shift >5 mm; no high or mixed density lesion >25 cc 
Table 1. 
4.2 Hypoxic brain injury 
Attempts have been made to identify prognostic factors for poor outcomes in patients with 
hypoxic brain injuries at up to 3 days after admission (Levy et al, 1985 and Zandbergen et al, 
2006). The American Academy of Neurology has published guidelines for prediction of 
outcomes in comatose survivors of cardiopulmonary resuscitation (Wijdicks et al 2006). 
Development of myoclonus status epilepticus within the 1st day, bilaterally absent cortical 
response on somatosensory evoked potentials (delayed N20) at day 1-3, serum neuron 
specific enolase (NSE) >33micrograms/L at day 1-3, absent pupillary or corneal reflexes on 
day 3 or extensor or absent motor response to stimulus on day 3 are predictive of poor 
neurologic outcomes.  
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Burst suppression or generalised epileptiform activity on EEG was predictive of poor 
outcome but with insufficient prognostic accuracy. Imaging (CT, MRI, PET) and duration of 
CPR were not reliable predictors of poor outcome. 
5. Determination of brain death 
Death has always had immense cultural and religious significance for human societies 
across the world. Until the Renaissance, there was no biological understanding of death. 
William Harvey’s seminal paper “On the Motion of the Heart and Blood in Animals” in the 
17th century laid the foundation to the understanding of death as irreversible cessation of 
cardiovascular function. In 1959, Wertheimer et al first described “death of the central 
nervous system” as a syndrome of coma, areflexia and apnoea. Later that year, Mollaret and 
Goulon coined the term “coma depasse” to describe this syndrome.  
Brain death is defined as irreversible cessation of brain function. Prior to the diagnosis of 
brain death being made, the following preconditions must be met 
• Definite clinical and/ or neuro imaging evidence of acute brain pathology consistent 
with irreversible loss of neurologic function (eg. traumatic brain injury, intracranial 
haemorrhage, hypoxic ischaemic encephalopathy) 
• Normothermic (temperature >35°C), normotensive (systolic BP>90 mmHg, MAP>60 
mHg) patient  
• Severe electrolyte (specifically sodium, magnesium, calcium, phosphate), metabolic 
(blood sugar, renal and hepatic functions) and endocrine disturbances ruled out 
• Effect of sedative drugs ruled out 
• Intact neuromuscular function 
For further clinical testing, the following are also essential  
• Ability to adequately examine brainstem reflexes including at least one ear and one eye 
• Ability to safely perform apnoea testing, which may be precluded by severe hypoxia or 
high cervical spine injury  
If the preconditions are met, brain death may be diagnosed by 
• Clinical examination OR 
• Demonstration of absence of intra cranial blood flow 
Clinical examination consists of 
• Absence of responsiveness for a period of observation AND 
• Absence of brainstem reflexes to clinical examination AND 
• Apnoea despite arterial pH<7.3, PaCO2>60 mmHg  
The American Academy of Neurology (AAN) guidelines (Wijdicks et al, 2010) comment that 
there is lack of evidence for a minimally acceptable observation period. The Australasian 
guidelines currently recommend a minimum 4 hour period of observation for 
unresponsiveness (The ANZICS Statement on Death and Organ donation).  
It is common practice in Australasia for clinical testing to be carried out independently by 2 
senior clinicians to confirm the diagnosis of brain death. This has been challenged in recent 
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times and, under the current AAN guidelines, confirmatory clinical testing by an 
independent clinician is no longer required. 
If clinical testing is inconclusive or cannot be carried out, Australasian practice would be to 
demonstrate absence of intra cranial blood flow by 
• 4 vessel (both carotid arteries, both vertebral arteries) intra arterial angiography with 
digital subtraction to demonstrate lack of blood flow above the level of the carotid 
siphon (anterior circulation) and the foramen magnum (posterior circulation) 
• Technetium 99m labelled hexamethyl propylene amine oxime (Tc-99m HMPAO) 
radionuclide scan demonstrating absence of intra cranial perfusion 
• Single photon emission computerised tomography (SPECT) 
• CT angiography 60 seconds after contrast bolus at the level of Circle of Willis 
demonstrating contrast enhancement of the external carotid but not of middle cerebral 
artery cortical branches, P2 segment of posterior cerebral arteries, pericallosal arteries 
and internal cerebral veins 
There is no documented case of a person who fulfils the preconditions and criteria for brain 
death ever subsequently developing any return of brain function.  
6. Illustrative cases 
6.1 Traumatic brain injury 
A 32 year old man was brought in by ambulance to the Emergency Department after being 
assaulted in a pub.  
At scene, he was noted to eye open to voice, localise to noxious stimuli and had incoherent 
speech. His heart rate was 98 and regular and his systolic blood pressure was 110 mmHg. 
The paramedics at the scene had basic life support skills only. Two large bore intravenous 
cannulae were inserted, fluid resuscitation with 0.9% NaCl commenced and the patient 
transferred with spinal precautions to the nearest trauma centre, about 5 minutes away.  
On arrival to hospital, he was moaning and unresponsive to pain. His haemodynamic status 
remained unchanged. 
In the trauma room, he was intubated with in line manual stabilisation, a cervical collar was 
applied and the head supported with sandbags and tape. He was ventilated with 100% oxygen 
to a PCO2 of 35-40 and sedated with morphine and midazolam. Primary and secondary 
surveys revealed no major limb, thorax, abdominal, pelvic or spinal trauma. There was no 
clinical evidence of base of skull fracture and his pupils were equal and reactive. He was taken 
for a non contrast CT of his head and neck. His cervical spine was intact and he was diagnosed 
as having an acute subdural haemorrhage about 15 mm in thickness over the left 
temporoparietal hemisphere with 5 mm midline shift. Subarachnoid blood was also noted. 
In the operating room, the subdural haemorrhage was evacuated with a craniotomy and an 
external ventricular drain (EVD) inserted. The patient was transferred to the intensive care 
unit intubated and ventilated. 
Over the next 24 hours, he remained deeply sedated with a combination of benzodiazepines, 
propofol and opiates and needed intermittent neuromuscular blockade with vecuronium. He 
required repeated drainage of CSF through his EVD and several administrations of 3% NaCl 
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to keep his ICP <20 mmHg. His MAP was manipulated with noradrenaline to maintain a CPP 
>60 mmHg. His pupils remained equal and reactive and normothermia and euglycemia 
maintained. In terms of extracranial organ support, he was ventilated to normocapnoea and 
SaO2 were maintained >92% at all times, with PEEP of 5 cmH2O. Apart from manipulation of 
MAP to maintain CPP >60mmHg, he remained cardiovascularly stable and his ECG remained 
unchanged from normal sinus rhythm. Enteral nutrition was commenced through an 
orogastric tube. Ranitidine was given intravenously for gut protection. Only mechanical 
thromboprophylaxis  with sequential calf compressors was provided.  
Over the subsequent 72 hours, the ICP remained stable at less than 20 mmHg and sedation 
was lightened. Pupils remained equal and no seizure activity was noted. The CT showed no 
further progression of brain pathology and some resolution of cerebral oedema. There were 
no other extracranial organ support issues. On day 5, the EVD was removed. On day 7, on 
sedation break, the patient was noted to eye open to voice, appropriately follow simple 
commands and cough to endotracheal suction. The patient was extubated and discharged to 
the neurosurgical ward for ongoing management. 
6.2 Posterior fossa bleed 
A 54 year old man with a background history of treated hypertension and a known 
posterior fossa arterio venous malformation presented to the Emergency Department with a 
decreased level of consciousness after complaining of a headache, slurred speech and 
unsteady gait. A CT scan revealed a large posterior fossa bleed from the AV malformation.  
The haematoma was emergently evacuated, the posterior fossa was decompressed and an 
external ventricular drain inserted. The patient was transferred to the intensive care unit.  
He was sedated with propofol and morphine, ICP maintained at <20 mmHg and the MAP 
was manipulated with noradrenaline to sustain a CPP >60 mmHg. Normocapnoea, 
normothermia, normoxia, normotension and euglycemia were maintained and routine 
postoperative cares were provided. His care was complicated by a rebleed in the posterior 
fossa on day 3 needing further decompression and ongoing sedation and CSF drainage. The 
ICP finally stabilized on day 6, a subsequent CT was satisfactory, the EVD was removed and 
on day 8, on sedation break, the patient was noted to be eye opening to voice and following 
simple commands. He was extubated the next day but needed to be re intubated soon after 
for inability to clear secretions.  
His stay was further complicated by a nosocomial pneumonia and a tracheostomy was 
performed to facilitate liberation from the ventilator over several days. There was 
reasonable recovery of motor and intellectual function, however, he failed attempts at 
decannulation due to inability to cough and clear secretions adequately. Interestingly, he 
was also noted to have central alveolar hypoventilation needing ventilator support during 
sleep (Ondine’s curse). A tracheostomy was left in situ and the patient transferred to a 
chronic ventilation service under the care of the respiratory medicine team. 
7. Conclusion 
Neurocritical care is a relatively new sub speciality of medicine. Critical care physicians in 
these units defragment the care of critically ill neurosurgical patients, often with other organ 
pathologies, by  
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• optimising treatment of the underlying brain pathology 
• preventing of secondary injury to neurons 
• providing global extracranial organ support 
The critical care unit itself provides a venue for advanced monitoring allowing 
• continuous monitoring of respiratory and haemodynamic function 
• continuous monitoring of ICP, allowing ongoing defence of CPP 
• monitoring of cerebral perfusion and cerebral tissue oxygenation   
This enables targeted aggressive invasive organ support to prevent or minimise secondary 
neuronal injury. Reasonable goals of resuscitation include 
• CPP>60 mmHg 
• PBrO2>15 mmHg 
• SjO2 55-75% 
• MAP>70 mmHg, ideally titrated to CPP if ICP measurement in situ or within 20% of 
patient’s baseline MAP, if known 
• SaO2>90% 
• PO2>70 mmHg 
• PCO2 35-45 mmHg 
• Temperature 36-37°C 
• Blood sugar 5-10 mmol/L 
• Urine output> 30 ml/hour (or at least 0.5 ml/kg/hour) 
Early aggressive management and prevention of secondary tissue injury in close 
coordination with neurosurgical teams is thought to improve neurologic outcomes for 
critically ill neurosurgical patients.  
There is now accumulating evidence of outcomes after critical illness. In neurosurgical 
populations, significant advances have been made in identifying indicators of poor 
outcome. A thorough understanding of these factors and their significance arms the bedside 
clinician in prognosticating for individual patients in their care. 
It is now about half a century since brain death as a phenomenon has been recognised. It is 
interesting that the diagnostic criteria and clinical examination to determine brain death 
have remained largely unchanged for over 30 years. Accumulating experience with various 
modalities of neuroimaging allow newer, more elegant ways of demonstrating absence of 
cerebral perfusion and are increasingly being used to diagnose brain death.  
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